Advanced Therapy Medicinal Products: How to Bring Cell-Based Medicinal Products Successfully to the Market - Report from the CAT-DGTI-GSCN Workshop at the DGTI Annual Meeting 2014

Publisher： Karger

E-ISSN： 1660-3818|42|3|194-199

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.42, Iss.3, 2015-04, pp. : 194-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

‘Sterility Testing of Blood Components and Advanced Therapy Medicinal Products’ (Munich, April 29, 2010) Organized by the DGTI Section ‘Safety in Hemotherapy’ – Meeting Report

By  

Transfusion Medicine and Hemotherapy, Vol. 38, Iss. 5, 2011-09 ,pp. : 334-336

Karger

Access to resources Recommend Favorite

‘Sterility Testing of Blood Components and Advanced Therapy Medicinal Products’ (Munich, April 29, 2010) Organized by the DGTI Section ‘Safety in Hemotherapy’ – Abstracts

By  

Transfusion Medicine and Hemotherapy, Vol. 38, Iss. 5, 2011-09 ,pp. : 337-340

Karger

Access to resources Recommend Favorite

Whither Advanced Therapy Medicinal Products?

By  

Transfusion Medicine and Hemotherapy, Vol. 40, Iss. 6, 2013-11 ,pp. : 449-452

Karger

Access to resources Recommend Favorite

European Regulatory Tools for Advanced Therapy Medicinal Products

By  

Transfusion Medicine and Hemotherapy, Vol. 40, Iss. 6, 2013-10 ,pp. : 409-412

Karger

Access to resources Recommend Favorite

Advanced Therapy Medicinal Products - a Multiple Challenge

By  

Transfusion Medicine and Hemotherapy, Vol. 40, Iss. 6, 2013-11 ,pp. : 384-385

Karger

Access to resources Recommend Favorite